# Intravenous Versus Oral Administration of Prednisolone in Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00311961** · PHASE4 · COMPLETED · sponsor: **Isala** · enrollment: 256 (—)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Intravenous prednisolone
- **DRUG:** Oral prednisolone

## Key facts

- **NCT ID:** NCT00311961
- **Lead sponsor:** Isala
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** 256 (—)
- **Last updated:** 2009-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00311961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00311961, "Intravenous Versus Oral Administration of Prednisolone in Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00311961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*